SCHEMBL28029943

SCHEMBL28029943

CC(=O)OCCC(C)(C)NC(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.36
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
CA9 Q16790 2/20 0.36
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 3/20 0.34
CHRM5 P08912 2/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
HTR1A P08908 1/20 0.34
CHRNB2 P17787 1/20 0.34
TBXA2R P21731 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA7 P36544 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21261831 0.82 TDP1 (0.42) CA12CA1CA2ALDH1A1TDP1
SCHEMBL22734080 0.81 CA12 (0.38) CA12CA1CA2CA9ALDH1A1
SCHEMBL6318013 0.81 TDP1 (0.37) CA12CA1CA2CA9ALDH1A1
SCHEMBL24145175 0.77 CA1 (0.40) CA12CA1CA2TDP1GAA
SCHEMBL11966911 0.77 ALDH1A1 (0.52) CA12CA1CA2ALDH1A1TDP1
SCHEMBL1359163 0.77 TDP1 (0.47) CA12CA1CA2ALDH1A1TDP1
SCHEMBL856099 0.77 TDP1 (0.39) CA12CA1CA2ALDH1A1TDP1
SCHEMBL28568915 0.76 CA12 (0.37) CA12CA1CA2CA9ALDH1A1
SCHEMBL24335698 0.76 TDP1 (0.37) CA12CA1CA2CA9TDP1
Hydrochloric Acid SCHEMBL20659338 0.76 TDP1 (0.38) CA12CA1CA2ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103649019-B Be used for the treatment of the 1-Piperazino-3-phenyl-indane of schizoid deuterate H. LUNDBECK A/S (DK) 2015-09-16 CN disclosed